Physician profile
David Luke Shellenberger
NPI 1487672556
$5,251.43
in general payments reported to CMS, 2019-2025
31 companies · $2,684 in 2025
The $2,684 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $261 · 2021: $462 · 2022: $262 · 2023: $535 · 2024: $840 · 2025: $2,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,277 · Consulting Fee: $1,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,276.66 |
| Consulting Fee | $1,781.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,759.36 | 2023-2025 | Inspire |
| Genzyme Corporation | $423.35 | 2022-2025 | |
| Acclarent, INC | $236.18 | 2021-2023 | Relieva Spinplus |
| Optinose US, INC. | $233.69 | 2019-2024 | |
| Glaxosmithkline, LLC. | $188.51 | 2022-2025 | Nucala |
| Stryker Corporation | $159.57 | 2019-2021 | |
| Integra Lifesciences Corporation | $142.29 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Alk-Abello, INC | $131.86 | 2019-2025 | Neffy, Timothy, Standardized, Standardized Mite D. Farinae |
| Regeneron Healthcare Solutions, INC. | $124.39 | 2021-2024 | Dupixent |
| Smith+Nephew, INC. | $106.66 | 2019-2025 | Tula, Halo |
| Sanofi-Aventis U.S. LLC | $100.93 | 2020-2021 | |
| Aerin Medical INC. | $72.72 | 2020-2025 | |
| Ethicon US, LLC | $66.73 | 2019-2024 | Harmonic |
| Medtronic, INC. | $57.31 | 2021-2024 | Nim Vital, Stealthstation S8 Platform |
| Hikma Pharmaceuticals USA | $55.39 | 2023-2025 | Ryaltris |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $43.07 | 2020-2021 | |
| Zoll Respicardia, INC. | $41.58 | 2023 | Remede System |
| Itamar Medical INC | $32.69 | 2023 | Watchpatone |
| Aytu Biopharma, INC. | $31.32 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $30.37 | 2021-2023 | |
| Kaleo, INC. | $29.01 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.61 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $27.29 | 2025 | Neffy |
| Olympus America INC. | $22.97 | 2023 | |
| Spirair, INC. | $19.01 | 2025 | |
| Hologic Sales and Service, LLC | $16.70 | 2024 | Coolseal Generator |
| Axogen | $15.29 | 2025 | |
| Davol INC. | $15.07 | 2020 | |
| Tactile Systems Technology INC | $13.86 | 2020 | |
| Phadia US INC. | $13.78 | 2020 | |
| Cochlear Americas | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shellenberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.